Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group
- PMID: 32814635
- PMCID: PMC7346773
- DOI: 10.1016/j.medcli.2020.06.020
Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group
Abstract
Background: SARS-CoV-2 infection is clinically very heterogeneous, varying from asymptomatic to severe clinical conditions with a fatal outcome. Some studies suggests that the ABO blood group could be a biological marker of susceptibility for the development of the disease.
Patients and methods: We collected data from patients admitted with COVID-19 infection who had ABO blood group recorded, and analyzed the incidence by groups, compared with the global population in Navarre, as well as their main complications and evolution.
Results: Group O was proportionally less represented in the hospitalized patients with respect to the global population, although the difference was not statistically significant. Group B had significantly higher rates of thrombotic complications and required more admissions in intensive care units.
Conclusion: The study suggests a lower susceptibility to infection in group O and a higher risk of complications in group B. Studies with a larger sample size are required in order to obtain significant results.
Keywords: Blood groups ABO; COVID-19; Coronavirus; Factor de von Willebrand; Factores de riesgo; Grupos sanguíneos ABO; Risk factors; SARS-CoV-2; Von Willebrand factor.
Copyright © 2020 Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group.Med Clin (Engl Ed). 2020 Oct 23;155(8):340-343. doi: 10.1016/j.medcle.2020.06.013. Epub 2020 Sep 26. Med Clin (Engl Ed). 2020. PMID: 33015369 Free PMC article.
-
COVID-19 and thrombosis: Beyond a casual association.Med Clin (Barc). 2020 Jul 10;155(1):44. doi: 10.1016/j.medcli.2020.04.014. Epub 2020 May 11. Med Clin (Barc). 2020. PMID: 32446683 Free PMC article. No abstract available.
-
Viral infection-induced thrombosis, novel coronavirus.J Vasc Surg. 2020 Aug;72(2):764-765. doi: 10.1016/j.jvs.2020.05.001. Epub 2020 May 11. J Vasc Surg. 2020. PMID: 32437948 Free PMC article. No abstract available.
-
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases.Eur J Prev Cardiol. 2020 Sep;27(13):1436-1437. doi: 10.1177/2047487320922370. Epub 2020 Apr 28. Eur J Prev Cardiol. 2020. PMID: 32343152 Free PMC article. Review. No abstract available.
-
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938149. doi: 10.1177/1076029620938149. Clin Appl Thromb Hemost. 2020. PMID: 32677459 Free PMC article. Review.
Cited by
-
Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study.Epidemiologia (Basel). 2022 Feb 10;3(1):49-67. doi: 10.3390/epidemiologia3010006. Epidemiologia (Basel). 2022. PMID: 36417267 Free PMC article.
References
-
- Zaho J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO Blood Group and the COVID-19 susceptibility, https://www.medrxiv.org/content/10.1101/2020.03.11.20031096v2. - PubMed
-
- Gallinaro L., Cattini M.G., Sztukowska M., Padrini R., Sartorello F., Pontara E. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood. 2008;111:3540–3545. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous